Description: Polynovo Limited, a medical device company, designs, develops, and manufactures dermal regeneration solutions in Australia. The company focuses on the development and commercialization of medical devices using its NovoSorb technology in the treatment of burns, surgical wounds, and negative pressure wound therapy. It offers BTM (biodegradable temporising matrix), a wound dressing intended for treatment of full-thickness wounds and burns. In addition, Polynovo Limited licensed its NovoSorb to Smith & Nephew for orthopaedic applications. The company was formerly known as Calzada Limited and changed its name to Polynovo Limited in November 2014. Polynovo Limited is based in Port Melbourne, Australia.
Home Page: polynovo.com
320 Lorimer Street
Port Melbourne,
VIC
3207
Australia
Phone:
61 3 8681 4050
Officers
| Name | Title |
|---|---|
| Mr. Jan-Marcel Gielen C.A. | CFO & Company Sec. |
| Dr. David McQuillan Ph.D. | Chief Technical & Scientific Officer |
| Mr. Swami Raote BPHARM, M.B.A. | CEO & Director |
| Mr. Ahmed Hassan | Director of Operations |
| Ms. Teena Chadha | APAC Marketing & Distributor Mang. |
| Ms. Monica Benyk | HR Mang. |
| Dr. Tim Moore | Principal Scientist |
| Mr. Edward Graubart | Sr. VP of Sales & Marketing (Americas) |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| Forward PE: | 30.303 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 79.3187 |
| Price-to-Sales TTM: | 26.1661 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 152 |